Volume 12, Number 10—October 2006
Dispatch
ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease
Erik R. Dubberke*
, Kimberly Reske*, L. Clifford McDonald†, and Victoria Fraser*‡
, Kimberly Reske*, L. Clifford McDonald†, and Victoria Fraser*‡
Table 1
Demographic characteristics of study population by Clostridium difficile–toxin assay (CDTA) and ICD-9 status*
| Characteristic | Controls, n = 44,585 (%) | CDTA+/ICD-9–, n = 156 (%) | CDTA+/ICD-9+, n = 506 (%) | CDTA–/ICD-9+, n = 239 (%) |
|---|---|---|---|---|
| Age (median y) | 55 | 64 | 67 | 66 |
| Length of hospitalization (median d) | 4 | 13 | 12 | 6 |
| Female | 25,869 (58) | 68 (44) | 267 (53) | 158 (66) |
| White | 28,071 (63) | 110 (71) | 347 (69) | 170 (71) |
| Time from admission to stool collection (median d) | NA | 6.0 | 3.0 | NA |
| First positive stool collected within 48 h of discharge | NA | 68 (44) | 72 (14) | NA |
*NA. not available.
Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential